Sensus Blog

The future of skin cancer treatment is now. Stay ahead of the curve with our library of informational blogs.

April
27
2026

Basal Cell Carcinoma vs. Squamous Cell Carcinoma: What’s the Difference?

Melanoma and non-melanoma are two primary categories of skin cancer. Each presents different symptoms and treatment options. Within the non-melanoma skin cancer – sometimes referred to as NMSC – category, the two most common types…

February
10
2022

Sensus Healthcare Reports Record Sales and Earnings for the 2021 Fourth Quarter

4Q21 diluted EPS of $0.32 on revenues of $13.0 million up 433% and 156%, respectively Affirms expectations for 1Q22 continued growth and full-year 2022 profitability Conference call begins at 4:30 p.m. Eastern time today BOCA…

February
10
2022

Report on Inner Arm excess skin relaxation treatment through Dermoelectroporation

Dr. A.Gessati*, *Aesthetic medicine Doctor, Milan, Italy.   Preliminary Study Dermoelectroporation, well known and established method for transdermal substances delivery without the use of needles, allows to get to important results for skin imperfection conditions,…

February
10
2022

Report on Hyaluronic Acid & Oligopeptides cocktail treatments through Dermoelectroporation

Dr. James Fulton, vivant Skin Care , Miami Florida, USA   Preliminary Study To evaluate the safety, tolerability and effectiveness of transdermal delivery of a Hyaluronic Acid & Oligopeptides cocktail for either facial lifting and…

February
10
2022

Report on Actinic Keratosis reduction treatment through Dermoelectroporation

Dr. Gabriela Vasilescu, M.D. Vascular Surgery Specialist, Martelli clinic, via del Bersaglio, 7 – Florence, Italy   Through Dermoelectroporation, the one and most innovative method for transdermal delivery of water based active ingredients into the…

Archives
Archives

IN THE NEWS

CEO Joseph Sardano on Coding for Superficial Radiation Therapy